Crandal Sp. z o.o. (Poland)

Main Activities: Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

Secondary Activities: Audio and Video Equipment Manufacturing | Navigational, Measuring, Electromedical, and Control Instruments Manufacturing | Manufacturing and Reproducing Magnetic and Optical Media | Medical Equipment and Supplies Manufacturing | All Other Miscellaneous Manufacturing | Office Equipment Merchant Wholesalers | Pharmacies and Drug Stores | Electronic and Precision Equipment Repair and Maintenance

Full name: Crandal Sp. z o.o.

Profile Updated: May 12, 2026

Crandal Sp. z o.o. is an enterprise based in Poland. Its main office is in Warsaw. It operates in the Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) industry. It was incorporated on July 28, 2021. Its’ total assets recorded a growth of 703.4%.

Headquarters
Ul. Domaniewska 47/10
Warsaw; Mazowieckie; Postal Code: 02-672

Contact Details: Purchase the Crandal Sp. z o.o. report to view the information.

Basic Information

Registered Capital:

Purchase the Crandal Sp. z o.o. report to view the information.

Financial Auditors:

Purchase the Crandal Sp. z o.o. report to view the information.

Incorporation Date:

July 28, 2021

Key Executives

Purchase this report to view the information.

President

Ownership Details

Purchase this report to view the information.

100%

Company Performance

Financial values in the chart are available after Crandal Sp. z o.o. report is purchased.

Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service

Key Financial Highlights

Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.

Total Operating Revenue

-77.25%▼

Operating Profit

-48.75%▼

EBITDA

-48.75%▼

Net Profit/Loss for the Period

-48.75%▼

Total Assets

703.4%▲

Total Equity

-120.64%▼

Return on Equity (ROE)

-26.95%▼

Similar companies